Gabriele Koller

Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: results from a randomized study

Michael Soyka, Christina Zingg, Gabriele Koller et al. · The International Journal of Neuropsychopharmacology · 2008 · 185 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Cannabinoid Receptor 1 Blocker Rimonabant (SR 141716) for Treatment of Alcohol Dependence

Michael Soyka, Gabriele Koller, Peggy Schmidt et al. · Journal of Clinical Psychopharmacology · 2008 · 128 citations

Medicine, Pharmacology, Pharmacotherapy +17

Association between suicide attempts and 5-HTTLPR-S-Allele in alcohol-dependent and control subjects: further evidence from a german alcohol-dependent inpatient sample

Ulrich W. Preuss, Gabriele Koller, Michael Soyka et al. · Biological Psychiatry · 2001 · 85 citations

Life Sciences, Psychiatry, Psychology +13

Cognitive Functioning During Methadone and Buprenorphine Treatment

Michael Soyka, Martin Lieb, Sabine Kagerer et al. · Journal of Clinical Psychopharmacology · 2008 · 80 citations

Medicine, Pharmacology, Psychology +17

Shared genetic risk between eating disorder‐ and substance‐use‐related phenotypes: Evidence from genome‐wide association studies

Melissa A. Munn‐Chernoff, Emma C. Johnson, Yi‐Ling Chou et al. · Addiction Biology · 2020 · 74 citations · Full text

Life Sciences, Genetics, Psychiatry +17